Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
Clinical trial NCT02754011 · COMPLETED
Trial details
- NCT number
- NCT02754011
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2022-02-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.